Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
European Crystal Network (ECN) was a Belgian contract research organization (CRO) specializing in protein crystallization and structural biology services. Founded as a spin-off from the University of Liège, the company provided high-throughput crystallization screening, optimization, and X-ray diffraction data collection to support drug discovery programs. ECN's core expertise facilitated structure-based drug design by delivering high-resolution three-dimensional structures of complex biological targets. In 2009, the company merged with Crelux GmbH, a German structural biology firm, to create a comprehensive service provider for the pharmaceutical industry. The legacy of ECN's operations is now part of WuXi AppTec, following its acquisition of Crelux in 2016.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European Crystal Network.